Overview

A Study of the Systemic Absorption of MOB015B

Status:
Completed
Trial end date:
2018-04-23
Target enrollment:
Participant gender:
Summary
A Study of the Systemic Absorption of Once Daily MOB015B when Applied for 28 Days in Subjects with Moderate to Severe Onychomycosis of the Toenails.
Phase:
Phase 1
Details
Lead Sponsor:
Moberg Pharma AB